Pfizer Sales Grow Stronger, Boosts Outlook
Pfizer sees higher sales for the year thanks to strong performance from drugs like Eliquis, even with lower COVID product sales.
Pfizer, a major drug company, just shared some good news. The company now expects to make more money this year than it first thought. This positive change comes from strong sales of its other medicines.
Sales of drugs like Eliquis and other products show great strength. This growth helps Pfizer raise its money outlook for the year. The company gives investors a better idea of its financial health.
Even with this good news, Pfizer expects less money from its COVID products. The company now predicts $4 billion from these sales, down from an earlier estimate of $5 billion. This shows a shift in what drives Pfizer's growth.
What does this mean for you? Pfizer's continued success can impact the larger healthcare market. It points to the power of diverse drug portfolios. This helps a company stay strong even when some product sales change.
Source: CNBC
More from Biotech
